Roquefort Therapeutics plc

ROQ.L · LSE
Analyze with AI
£1.30+£0.00 (+0%)
At close:Dec 19, 2025, 4:21 PM UTC
P/E TTM-2.17
P/B TTM0.4
P/S TTM0
Dividend Yield0%
EPS-£0.01
Beta-0.434
Valuation
PEG Ratio-0.14
FCF Yield-30.33%
EV / EBITDA-2.51
More On Valuation »
Quality
ROIC-19.86%
Gross Margin0.00%
Cash Conv. Ratio0.67
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth56.16%
More On Growth »
Safety
Net Debt / EBITDA-0.22
Interest Coverage-12.79
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-18,059.12
More On Efficiency »

Roquefort Therapeutics plc (ROQ.L) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Roquefort Therapeutics plc (ROQ.L) stock price today?

As of Dec 19, 2025, 4:21 PM UTC, Roquefort Therapeutics plc (ROQ.L) stock is trading at £1.30. The stock price is quoted in GBP and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ROQ.L stock quotes for informed trading decisions.

What is Roquefort Therapeutics plc's market capitalization?

Roquefort Therapeutics plc (ROQ.L) has a market capitalization of approximately $2.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Roquefort Therapeutics plc's size relative to other companies in the GBP market. The market cap figure updates automatically as the ROQ.L stock price changes.

What is the 52-week range for Roquefort Therapeutics plc stock?

Roquefort Therapeutics plc (ROQ.L) stock has traded in a 52-week range of £1.08 — £5.50. The 52-week range shows the highest and lowest prices at which ROQ.L traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Roquefort Therapeutics plc stock price to this range provides context for recent price action.

How much trading volume does Roquefort Therapeutics plc stock have?

Roquefort Therapeutics plc (ROQ.L) stock recently traded approximately 94K shares. Trading volume indicates market liquidity and investor interest in ROQ.L. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Roquefort Therapeutics plc stock.

Does Roquefort Therapeutics plc pay dividends to shareholders?

Yes, Roquefort Therapeutics plc (ROQ.L) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Roquefort Therapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Roquefort Therapeutics plc's intraday price range?

Today, Roquefort Therapeutics plc (ROQ.L) stock has traded in a range of £1.20 — £1.30. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ROQ.L's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Roquefort Therapeutics plc stock data?

AlphaPilot sources real-time ROQ.L stock quotes, fundamental financial data, and historical price charts for Roquefort Therapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Roquefort Therapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ROQ.L stock performance.